Trexquant Investment’s Cymabay Therapeutics CBAY Stock Holding History

Trexquant Investment’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-219,755	Closed	-$3.28M	–	1887
2023 Q3	$3.28M	Buy	219,755 +163,278	+289%	+$2.16M	0.08%	338
2023 Q2	$618K	Sell	56,477 -7,409	-12%	-$69K	0.02%	927
2023 Q1	$557K	Buy	+63,886	New	+$511K	0.02%	952
2021 Q1	–	Sell	-52,695	Closed	-$302K	–	1551
2020 Q4	$302K	Buy	+52,695	New	+$399K	0.03%	687
2019 Q2	–	Sell	-11,794	Closed	-$157K	–	1200
2019 Q1	$157K	Buy	+11,794	New	+$125K	0.01%	899
2018 Q1	–	Sell	-22,511	Closed	-$207K	–	1456
2017 Q4	$207K	Buy	+22,511	New	+$192K	0.02%	926

Other funds holding CBAY

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Trexquant Investment's CBAY Position: Q4 2023 in Review

Trexquant Investment sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 219,755 shares — an estimated $3.28M sold.

Trexquant Investment first reported a position in CBAY in Q4 2017 and held it in 6 quarters. The position peaked at $3.28M in Q3 2023. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.

Trexquant Investment reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
Trexquant Investment sold 219,755 Cymabay Therapeutics shares in Q4 2023, an estimated $3.28M.
Trexquant Investment first reported a position in Cymabay Therapeutics in Q4 2017 and held it in 6 quarters.
Trexquant Investment's Cymabay Therapeutics position peaked at $3.28M in Q3 2023.
200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.